HBsAg Loss and Hepatocellular Carcinoma Surveillance: One Size Does Not Fit All
admin
The Publisher regrets that this article is an accidental duplication of an article that has already been published, ...
We read with interest the randomized controlled trial by Hirode et al1 evaluating whether adding serum biomarkers (α-fetoprotein , AFP-L3, and ...
We read with great interest the study by Hirode et al1 regarding the utility of adding serum biomarkers (BMs) to ultrasound (US) for hepatocellular ...
We read with great interest the study from Hirode et al1 comparing ultrasound alone with ultrasound plus serum biomarkers (α-fetoprotein , AFP-L3, and ...
People with hepatitis B who lose surface antigen at younger ages and have no cirrhosis have very low hepatocellular carcinoma risk, suggesting surveillance ...
α-Fetoprotein (AFP), a serum glycoprotein, is the first and most well-validated biomarker for hepatocellular carcinoma (HCC) detection.1 Although AFP has ...
In this study, we estimated the serum alpha-fetoprotein test’s performance for liver cancer screening in patients with cirrhosis. We found that lowering the ...